EUVIMEDEUVIMED entdecken
CrossrefInfokarte

A Canadian population-based observational cohort study of alpha and beta-thalassemia syndromes in pregnancy

Nathalie Auger, Delphine Dubois, Shu Qin Wei, Aimina Ayoub, Jessica Healy-Profitós, Gabriel Côté-Corriveau

Acta Haematologica · 2026-10-29

DOI: 10.1159/aha/abkag021 ↗
AbstractBibliografische Angaben

Abstract

Introduction: Beta-thalassemia can adversely affect pregnancy, but the impact of alpha-thalassemia is less studied. We assessed whether patients with symptomatic alpha-thalassemia have similar pregnancy outcomes as patients with symptomatic beta-thalassemia. Methods: We conducted a population-based retrospective cohort study of 1,324,488 pregnancies in Quebec, Canada, between 2006 and 2022. The exposures were maternal symptomatic alpha-thalassemia, symptomatic beta-thalassemia, thalassemia trait, and other thalassemia syndromes. Primary outcomes were severe maternal morbidity, preterm birth, preeclampsia, and other pregnancy complications. We used log-binomial regression models to estimate adjusted risk ratios (RR) and 95% confidence intervals (CI) for the association between each thalassemia and adverse pregnancy outcomes. Results: In total, 825 patients had symptomatic alpha-thalassemia, 681 symptomatic beta-thalassemia, 1,749 thalassemia trait, and 2,377 other thalassemia syndromes. Compared with no thalassemia, alpha-thalassemia (RR 3.05; 95% CI: 2.36-3.94) and beta-thalassemia (RR 2.52; 95% CI: 1.84-3.45) were associated with a greater risk of severe maternal morbidity. However, alpha-thalassemia was additionally associated with preterm birth (RR 1.45; 95% CI: 1.16-1.82), preeclampsia (RR 1.67; 95% CI: 1.27-2.20), and gestational diabetes (RR 1.79; 95% CI: 1.52-2.09). Beta-thalassemia was not associated with these outcomes, and associations were weak for thalassemia trait and other thalassemias. Conclusion: The findings suggest that symptomatic alpha-thalassemia is associated with a wider range of pregnancy complications than symptomatic beta-thalassemia and other thalassemia syndromes. However, symptomatic alpha and beta-thalassemia are both associated with severe maternal morbidity.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →